<SEC-DOCUMENT>0001104659-23-030736-index.html : 20230309
<SEC-HEADER>0001104659-23-030736.hdr.sgml : 20230309
<ACCEPTANCE-DATETIME>20230309210725
ACCESSION NUMBER:		0001104659-23-030736
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230307
FILED AS OF DATE:		20230309
DATE AS OF CHANGE:		20230309

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Odlander Bjorn
		CENTRAL INDEX KEY:			0001488799

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36296
		FILM NUMBER:		23721421

	MAIL ADDRESS:	
		STREET 1:		C/O ODLANDER, FREDRIKSON & CO. AB
		STREET 2:		STRANDVAGEN 5B
		CITY:			STOCKHOLM
		STATE:			V7
		ZIP:			SE-114 51

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Carisma Therapeutics Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262025616
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		2674916422

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sesen Bio, Inc.
		DATE OF NAME CHANGE:	20180516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm238905d11_3seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm238905d11_3seq1.html

Document 1 - RAW XML: tm238905d11_3seq1.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>tm238905d11_ex24-1.htm
<DESCRIPTION>EXHIBIT 24.1
<TEXT>
Document 2 - file: tm238905d11_ex24-1.htm

</DOCUMENT>
</SEC-DOCUMENT>